Celldex Therapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $551k | 21k | 25.87 |
| 2025-06-30 | $314k | 15k | 20.35 |
| 2025-03-31 | $411k | 23k | 18.15 |
| 2024-12-31 | $744k | 29k | 25.27 |
| 2024-09-30 | $631k | 19k | 33.99 |
| 2024-06-30 | $833k | 23k | 37.01 |
| 2024-03-31 | $1.3M | 30k | 41.97 |
| 2023-09-30 | $772k | 28k | 27.52 |
| 2023-06-30 | $1.3M | 37k | 33.93 |
| 2023-03-31 | $985k | 27k | 35.98 |